Stage IB Pancreatic Cancer Suspended Phase 1 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0034490 (Stage IB Pancreatic Cancer)Suspended1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01918644Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic CancerTreatment